Skip to main content

The Adenoid Cystic Carcinoma Research Foundation

Needham, Massachusetts·EIN 20-6745475·NTEE H12 · Medical Research·501(c)(3)·Filing year 2024

The Adenoid Cystic Carcinoma Research Foundation's highest-paid officer, the Executive Director/board C, was reported at $150,000 for 2024 (IRS Form 990), including base pay and other compensation. Reported CEO pay ranged from $150,000 to $150,000 between 2023 and 2024.

Total revenue
$1.1M
Total assets
$2.3M
Total expenses
$1.5M
Reported officers
9

How The Adenoid Cystic Carcinoma Research Foundation’s pay compares

Compared with Medical Research organizations of similar size in Massachusetts.

In line with peers

Most of the roles The Adenoid Cystic Carcinoma Research Foundation reports are paid within the middle half of what these Medical Research organizations pay for the same roles.

Show how each role compares

From the officer pay The Adenoid Cystic Carcinoma Research Foundation reported on its latest IRS Form 990.

THE ADENOID CYSTIC CARCINOMA RESEARCH FOUNDATION (ACCRF) SUPPORTS RESEARCH INTO ADENOID CYSTIC CARCINOMA THAT WILL ACCELERATE THE DEVELOPMENT OF IMPROVED THERAPIES AND A CURE FOR THE DISEASE.

Executive compensation

Form 990 · Part VII & Schedule J · 2 reported individuals · Filing year 2024

Executive Director/board C
Other
$150k
Director of Research
Highest Compensated Employee
Median to 75th percentileOn the typical range for this role
$143k

Plus 7 unpaid individuals.

Browse compensation in Medical Research →

Top pay as a share of expenses

In 2024, the highest total compensation at The Adenoid Cystic Carcinoma Research Foundation equaled 10% of the organization's total expenses. The median for medical research organizations is 10%.

This organization (2024)
10%
Sector median
10%
Middle half of sector
4% to 21%

Based on 1,115 medical research organizations, each measured at its most recent filing year with reported expenses and compensation.

Held steady
from 2023

From $150k in 2023 to $150k in 2024.

$150k
2023
$150k
2024
Pay for the position

Highest Compensated Employee pay rose 6% from 2023 to 2024, while revenue fell 39%.

$135k in 2023 to $143k in 2024.

Pay for the position itself, not any one person. The officeholder may have changed between 2023 and 2024.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Common questions about The Adenoid Cystic Carcinoma Research Foundation

What does the Highest Compensated Employee of The Adenoid Cystic Carcinoma Research Foundation earn?

In 2024, the Highest Compensated Employee of The Adenoid Cystic Carcinoma Research Foundation received $142,500 in total compensation. This pay is within the typical range for Highest Compensated Employee roles, the same range the role page shows for organizations like this one: between the median and the 75th percentile.

What are The Adenoid Cystic Carcinoma Research Foundation's revenue and expenses?

In 2024, The Adenoid Cystic Carcinoma Research Foundation reported $1.1M in total revenue and $1.5M in total expenses on its IRS Form 990.